Is osimertinib/osimertinib effective for the pain of bone metastasis?

Osimertinib/Osimertinib can relieve the pain caused by bone metastasis in patients with advanced non-small cell lung cancer (NSCLC) to a certain extent. Bone metastasis is one of the common complications of NSCLC, which can lead to bone pain, fractures, dysfunction and other symptoms, seriously affecting the patient's quality of life. Osimertinib/OsimertinibAs a targeted therapy, it can interfere with the growth and spread of tumor cells, including its impact on bone metastasis. Studies have shown that Osimertinib can inhibit the growth of tumors in bones and reduce the pain associated with bone metastasis. In addition, Osimertinib/Osimertinib can also improve the quality of life of patients with bone metastases and prolong progression-free survival and overall survival.